Primemd Valuation
| PRMD Stock | USD 0.0005 0.0002 66.67% |
Primemd seems to be overvalued based on Macroaxis valuation methodology. Our model determines the value of Primemd from analyzing the company fundamentals such as Return On Equity of -0.0685, operating margin of (0.58) %, and Price To Book of 0.07 X as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Primemd's price fluctuation is out of control at this time. Calculation of the real value of Primemd is based on 3 months time horizon. Increasing Primemd's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Primemd pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Primemd. Since Primemd is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Primemd Pink Sheet. However, Primemd's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5.0E-4 | Real 3.78E-4 | Hype 5.0E-4 | Naive 4.99E-4 |
The real value of Primemd Pink Sheet, also known as its intrinsic value, is the underlying worth of Primemd Company, which is reflected in its stock price. It is based on Primemd's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Primemd's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Primemd helps investors to forecast how Primemd pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Primemd more accurately as focusing exclusively on Primemd's fundamentals will not take into account other important factors: Primemd Total Value Analysis
Primemd is at this time expected to have valuation of 76.82 K with market capitalization of 76.82 K, debt of , and cash on hands of 435.5 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Primemd fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
76.82 K | 76.82 K | 435.5 K |
Primemd Investor Information
The company has price-to-book ratio of 0.07. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Primemd recorded a loss per share of 0.03. The entity had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Primemd's historical financial statements, Primemd is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Primemd Asset Utilization
One of the ways to look at asset utilization of Primemd is to check how much profit was generated for every dollar of assets it reports. Primemd holds a negative application of assets of -0.0182 pct., losing $1.82E-4 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of Primemd shows how discouraging it operates for each dollar spent on its assets.Primemd Profitability Analysis
The company reported the previous year's revenue of 69.98 K. Net Loss for the year was (101.12 K) with profit before overhead, payroll, taxes, and interest of 67.8 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Primemd's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Primemd and how it compares across the competition.
About Primemd Valuation
The pink sheet valuation mechanism determines Primemd's current worth on a weekly basis. Our valuation model uses a comparative analysis of Primemd. We calculate exposure to Primemd's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Primemd's related companies.Primemd Inc., together with its subsidiaries, is engaged in the purchase and development of residential and commercial real estate properties in the United States. The company was formerly known as Eagle Exploration Co. and changed its name to Primemd Inc. in June 2021. Primemd is traded on OTC Exchange in the United States.
8 Steps to conduct Primemd's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Primemd's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Primemd's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Primemd's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Primemd's revenue streams: Identify Primemd's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Primemd's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Primemd's growth potential: Evaluate Primemd's management, business model, and growth potential.
- Determine Primemd's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Primemd's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Primemd Growth Indicators
Investing in growth stocks can be very risky. If the company such as Primemd does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Retained Earnings | -5.4 M | |
| Quarterly Revenue Growth Y O Y | -0.578 |
Complementary Tools for Primemd Pink Sheet analysis
When running Primemd's price analysis, check to measure Primemd's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Primemd is operating at the current time. Most of Primemd's value examination focuses on studying past and present price action to predict the probability of Primemd's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Primemd's price. Additionally, you may evaluate how the addition of Primemd to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |